CA
NZ
UK
AU
IND
US
• The stock options feature an exercise price of $18.40 tied to current market conditions.
• Irrigation segment performance weakened, counterbalancing growth in the company’s road safety business.
• The underwriting syndicate, led by William Blair & Company and D.A. Davidson & Co. Received an option for an extra 833,333 shares.
• The Board's size has increased to nine members following Bush's election.
• The agreement includes provisions for swingline loans and letters of credit up to $200 million and $250 million respectively.
• The fiscal period ending May 31, 2026, showed that earnings missed analysts' expectations.
• The $0.15 payout reflects the company’s ongoing commitment to preferred stockholders amid sector volatility.
• HCW Biologics eliminated a $2.8 million disputed payable through a settlement finalized by June 30 2026.
• The establishment of this subsidiary underscores PMGC's commitment to advancing healthcare solutions.
• A company press release announced the completion and is attached to the regulatory filing.
Please wait processing your request...